Healthcare provider profile · identity verified

Maggie Jones

Physician Assistant · LILLINGTON, NC · NPI 1053903401

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Sertraline Hcl	Sertraline Hcl	262	35
Lisinopril	Lisinopril	234	43
Atorvastatin Calcium	Atorvastatin Calcium	228	53
Furosemide	Furosemide	223	43
Levothyroxine Sodium	Levothyroxine Sodium	221	38
Omeprazole	Omeprazole	190	41
Amlodipine Besylate	Amlodipine Besylate	188	37
Gabapentin	Gabapentin	181	45
Eliquis	Apixaban	175	27
Donepezil Hcl	Donepezil Hcl	157	34
Pantoprazole Sodium	Pantoprazole Sodium	146	25
Trazodone Hcl	Trazodone Hcl	146	26
Potassium Chloride	Potassium Chloride	129	33
Losartan Potassium	Losartan Potassium	126	26
Metoprolol Tartrate	Metoprolol Tartrate	125	19
Quetiapine Fumarate	Quetiapine Fumarate	118	16
Metformin Hcl	Metformin Hcl	116	22
Tamsulosin Hcl	Tamsulosin Hcl	101	19
Escitalopram Oxalate	Escitalopram Oxalate	92	16
Duloxetine Hcl	Duloxetine Hcl	90	13
Memantine Hcl	Memantine Hcl	82	15
Myrbetriq	Mirabegron	81	16
Mirtazapine	Mirtazapine	80	14
Olanzapine	Olanzapine	80	11
Carvedilol	Carvedilol	79	18
Hydrochlorothiazide	Hydrochlorothiazide	76	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	72	35
Citalopram Hbr	Citalopram Hydrobromide	71	suppressed
Oxycodone Hcl	Oxycodone Hcl	70	23
Allopurinol	Allopurinol	63	suppressed
Buspirone Hcl	Buspirone Hcl	61	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	46
Metoprolol Succinate	Metoprolol Succinate	56	16
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	11
Albuterol Sulfate Hfa	Albuterol Sulfate	50	16
Aripiprazole	Aripiprazole	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	11
Cephalexin	Cephalexin	45	14
Diclofenac Sodium	Diclofenac Sodium	43	suppressed
Atenolol	Atenolol	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Pregabalin	Pregabalin	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Nystatin	Nystatin	37	17
Tramadol Hcl	Tramadol Hcl	37	12
Xarelto	Rivaroxaban	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	14
Rosuvastatin Calcium	Rosuvastatin Calcium	36	suppressed
Torsemide	Torsemide	36	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Celecoxib	Celecoxib	33	suppressed
Estradiol	Estradiol	33	suppressed
Ketoconazole	Ketoconazole	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Finasteride	Finasteride	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Ondansetron Odt	Ondansetron	27	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Olanzapine Odt	Olanzapine	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Prednisone	Prednisone	23	15
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	17
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Diazepam	Diazepam	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Famotidine	Famotidine	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Fentanyl	Fentanyl	19	suppressed
Methimazole	Methimazole	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Levofloxacin	Levofloxacin	17	15
Methadone Hcl	Methadone Hcl	17	suppressed
Nyamyc	Nystatin	17	suppressed
Risperidone	Risperidone	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Primidone	Primidone	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Fluconazole	Fluconazole	15	11
Ibuprofen	Ibuprofen	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lorazepam	Lorazepam	15	11
Naproxen	Naproxen	15	suppressed
Cefdinir	Cefdinir	14	11
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Topiramate	Topiramate	14	suppressed
Valsartan	Valsartan	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Loperamide	Loperamide Hcl	12	11
Lumigan	Bimatoprost	12	suppressed
Nystop	Nystatin	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Minoxidil	Minoxidil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error